{"product_id":"an-aid-to-the-mrcp-paces-volume-3-9781118348055","title":"An Aid to the MRCP PACES Volume 3","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003eAn Aid to the MRCP PACES Volume 3: Station 5 is a brand new, fully updated edition of the best-selling PACES revision guide to address the newest Station, covering Integrated Clinical Assessment, with content guided by the experiences of PACES candidates.\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003e\u003cp\u003ePreface ix\u003c\/p\u003e \u003cp\u003eIntroduction xiii\u003c\/p\u003e \u003cp\u003eSection G: Examination Routines 1\u003c\/p\u003e \u003cp\u003e1 Pulse 7\u003c\/p\u003e \u003cp\u003e2 Heart 8\u003c\/p\u003e \u003cp\u003e3 Chest 13\u003c\/p\u003e \u003cp\u003e4 Abdomen 17\u003c\/p\u003e \u003cp\u003e5 Visual fields 22\u003c\/p\u003e \u003cp\u003e6 Cranial nerves 23\u003c\/p\u003e \u003cp\u003e7 Arms 26\u003c\/p\u003e \u003cp\u003e8 Legs 30\u003c\/p\u003e \u003cp\u003e9 Legs and arms 34\u003c\/p\u003e \u003cp\u003e10 Gait 35\u003c\/p\u003e \u003cp\u003e11 Ask some questions 36\u003c\/p\u003e \u003cp\u003e12 Fundi 39\u003c\/p\u003e \u003cp\u003e13 Eyes 43\u003c\/p\u003e \u003cp\u003e14 Face 45\u003c\/p\u003e \u003cp\u003e15 Hands 47\u003c\/p\u003e \u003cp\u003e16 Skin 51\u003c\/p\u003e \u003cp\u003e17 Rash 53\u003c\/p\u003e \u003cp\u003e18 Neck 54\u003c\/p\u003e \u003cp\u003e19 Thyroid status 56\u003c\/p\u003e \u003cp\u003e20 Knee 58\u003c\/p\u003e \u003cp\u003e21 Hip 60\u003c\/p\u003e \u003cp\u003e22 What is the diagnosis? 61\u003c\/p\u003e \u003cp\u003eSection H: Integrated Clinical Assessment 65\u003c\/p\u003e \u003cp\u003eStation 5 Scenarios by specialty 75\u003c\/p\u003e \u003cp\u003eDermatology\u003c\/p\u003e \u003cp\u003e1 Non-resolving leg ulcer: pyoderma gangrenosum 77\u003c\/p\u003e \u003cp\u003e2 Generalized rash: psoriasis 81\u003c\/p\u003e \u003cp\u003e3 Dermatomyositis and falls 85\u003c\/p\u003e \u003cp\u003eRheumatology\u003c\/p\u003e \u003cp\u003e4 Systemic sclerosis and Raynaud’s syndrome 90\u003c\/p\u003e \u003cp\u003e5 Rheumatoid arthritis and effects on activities of daily living (ADL) 94\u003c\/p\u003e \u003cp\u003e6 Psoriatic arthropathy 98\u003c\/p\u003e \u003cp\u003e7 Ankylosing spondylitis: short notes 101\u003c\/p\u003e \u003cp\u003e8 Gout: short notes 102\u003c\/p\u003e \u003cp\u003e9 Steroid toxicity: short notes 103\u003c\/p\u003e \u003cp\u003eEndocrine\u003c\/p\u003e \u003cp\u003e10 Thyroid eye disease 105\u003c\/p\u003e \u003cp\u003e11 Acromegaly 109\u003c\/p\u003e \u003cp\u003e12 Diabetes mellitus and Charcot joint 112\u003c\/p\u003e \u003cp\u003e13 Diabetes mellitus: foot ulcer and diabetes control 116\u003c\/p\u003e \u003cp\u003e14 Goitre and weight loss 119\u003c\/p\u003e \u003cp\u003eEyes\u003c\/p\u003e \u003cp\u003e15 Retinitis pigmentosa 125\u003c\/p\u003e \u003cp\u003e16 Optic atrophy 128\u003c\/p\u003e \u003cp\u003e17 Visual blurring in a patient with diabetes mellitus 132\u003c\/p\u003e \u003cp\u003eGastroenterology\u003c\/p\u003e \u003cp\u003e18 Iron deficiency anaemia 137\u003c\/p\u003e \u003cp\u003e19 Haematemesis 141\u003c\/p\u003e \u003cp\u003e20 Elevated liver function tests: non-alcoholic fatty liver disease (NAFLD) 146\u003c\/p\u003e \u003cp\u003e21 Elevated liver function tests and hepatitis B serology 151\u003c\/p\u003e \u003cp\u003e22 Crohn’s disease\/inflammatory bowel disease 155\u003c\/p\u003e \u003cp\u003e23 Dysphagia and weight loss 158\u003c\/p\u003e \u003cp\u003e24 Diarrhoea: recent antibiotics 162\u003c\/p\u003e \u003cp\u003e25 Weight loss 166\u003c\/p\u003e \u003cp\u003e26 Gastrointestinal bleed: significant bleed 169\u003c\/p\u003e \u003cp\u003eHaematology\u003c\/p\u003e \u003cp\u003e27 Anaemia 173\u003c\/p\u003e \u003cp\u003e28 Easy bruising\/idiopathic thrombocytopenic purpura 176\u003c\/p\u003e \u003cp\u003e29 Epistaxis\/elevated international normalized ratio (INR) 180\u003c\/p\u003e \u003cp\u003e30 Neutropenic sepsis 184\u003c\/p\u003e \u003cp\u003eCardiology\u003c\/p\u003e \u003cp\u003e31 Young syncope 188\u003c\/p\u003e \u003cp\u003e32 Angina\/chest pain 193\u003c\/p\u003e \u003cp\u003e33 Palpitations ?atrial fibrillation 197\u003c\/p\u003e \u003cp\u003e34 Breathlessness\/congestive cardiac failure 201\u003c\/p\u003e \u003cp\u003e35 Syncope\/aortic stenosis 205\u003c\/p\u003e \u003cp\u003e36 Syncope (orthostatic) 208\u003c\/p\u003e \u003cp\u003eRespiratory\u003c\/p\u003e \u003cp\u003e37 Chronic obstructive pulmonary disease (COPD) 211\u003c\/p\u003e \u003cp\u003e38 Asthma 214\u003c\/p\u003e \u003cp\u003e39 Pleural effusion 217\u003c\/p\u003e \u003cp\u003e40 Short of breath ?pulmonary embolism 221\u003c\/p\u003e \u003cp\u003e41 Rheumatoid arthritis\/breathlessness 226\u003c\/p\u003e \u003cp\u003e42 Haemoptysis 229\u003c\/p\u003e \u003cp\u003eNeurology\u003c\/p\u003e \u003cp\u003e43 Headache: progressive\/memory issues 233\u003c\/p\u003e \u003cp\u003e44 Headache: migraine 236\u003c\/p\u003e \u003cp\u003e45 Subarachnoid haemorrhage 240\u003c\/p\u003e \u003cp\u003e46 Transient ischaemic attack: loss of vision 243\u003c\/p\u003e \u003cp\u003e47 Left-sided weakness in a young woman 247\u003c\/p\u003e \u003cp\u003e48 Parkinson’s disease\/falls in an elderly woman 250\u003c\/p\u003e \u003cp\u003e49 Cranial nerve VI palsy: sudden onset 254\u003c\/p\u003e \u003cp\u003e50 Blackout: first fit 258\u003c\/p\u003e \u003cp\u003e51 Essential tremor 263\u003c\/p\u003e \u003cp\u003e52 Temporal arteritis 267\u003c\/p\u003e \u003cp\u003e53 Carpal tunnel syndrome 270\u003c\/p\u003e \u003cp\u003e54 Multiple sclerosis\/diplopia 274\u003c\/p\u003e \u003cp\u003e55 Peripheral neuropathy 279\u003c\/p\u003e \u003cp\u003eMiscellaneous cases\u003c\/p\u003e \u003cp\u003e56 Urinary tract infection: male\/sexual history 283\u003c\/p\u003e \u003cp\u003e57 Swollen calf in a young woman 287\u003c\/p\u003e \u003cp\u003e58 Deep venous thrombosis (DVT) secondary to neoplasia: elderly patient 291\u003c\/p\u003e \u003cp\u003e59 Deterioration in renal function 295\u003c\/p\u003e \u003cp\u003e60 Fever in the returning traveller 299\u003c\/p\u003e \u003cp\u003eSection I: Short Case Records 305\u003c\/p\u003e \u003cp\u003eStation 5 Skin 309\u003c\/p\u003e \u003cp\u003e1 Systemic sclerosis\/CREST syndrome 311\u003c\/p\u003e \u003cp\u003e2 Neurofibromatosis (von Recklinghausen’s disease) 312\u003c\/p\u003e \u003cp\u003e3 Osler–Weber–Rendu syndrome 314\u003c\/p\u003e \u003cp\u003e4 Psoriasis 316\u003c\/p\u003e \u003cp\u003e5 Rash of uncertain cause 318\u003c\/p\u003e \u003cp\u003e6 Dermatomyositis 319\u003c\/p\u003e \u003cp\u003e7 Xanthomata 321\u003c\/p\u003e \u003cp\u003e8 Vitiligo 324\u003c\/p\u003e \u003cp\u003e9 Adenoma sebaceum in tuberous sclerosis complex 328\u003c\/p\u003e \u003cp\u003e10 Pseudoxanthoma elasticum 330\u003c\/p\u003e \u003cp\u003e11 Lichen planus 333\u003c\/p\u003e \u003cp\u003e12 Yellow nail syndrome 335\u003c\/p\u003e \u003cp\u003e13 Gouty tophi 336\u003c\/p\u003e \u003cp\u003e14 Alopecia areata 337\u003c\/p\u003e \u003cp\u003e15 Eczema 339\u003c\/p\u003e \u003cp\u003e16 Pretibial myxoedema 342\u003c\/p\u003e \u003cp\u003e17 Clubbing 343\u003c\/p\u003e \u003cp\u003e18 Necrobiosis lipoidica diabeticorum 345\u003c\/p\u003e \u003cp\u003e19 Lupus pernio 347\u003c\/p\u003e \u003cp\u003e20 Tinea 350\u003c\/p\u003e \u003cp\u003e21 Koilonychia 352\u003c\/p\u003e \u003cp\u003e22 Raynaud’s phenomenon 353\u003c\/p\u003e \u003cp\u003e23 Erythema nodosum 355\u003c\/p\u003e \u003cp\u003e24 Sturge–Weber syndrome 358\u003c\/p\u003e \u003cp\u003e25 Purpura 360\u003c\/p\u003e \u003cp\u003e26 Peutz–Jeghers syndrome 363\u003c\/p\u003e \u003cp\u003e27 Vasculitis 364\u003c\/p\u003e \u003cp\u003e28 Ehlers–Danlos syndrome 366\u003c\/p\u003e \u003cp\u003e29 Livedo reticularis 368\u003c\/p\u003e \u003cp\u003e30 Pemphigus\/pemphigoid 370\u003c\/p\u003e \u003cp\u003e31 Radiation burn on the chest 373\u003c\/p\u003e \u003cp\u003e32 Herpes zoster 374\u003c\/p\u003e \u003cp\u003e33 Henoch–Schönlein purpura 376\u003c\/p\u003e \u003cp\u003e34 Mycosis fungoides 378\u003c\/p\u003e \u003cp\u003e35 Morphoea 380\u003c\/p\u003e \u003cp\u003e36 Kaposi’s sarcoma (AIDS) 382\u003c\/p\u003e \u003cp\u003e37 Porphyria 385\u003c\/p\u003e \u003cp\u003e38 Lupus vulgaris 387\u003c\/p\u003e \u003cp\u003e39 Dermatitis herpetiformis 389\u003c\/p\u003e \u003cp\u003e40 Urticaria pigmentosa (mastocytosis) 391\u003c\/p\u003e \u003cp\u003e41 Palmoplantar keratoderma (tylosis) 393\u003c\/p\u003e \u003cp\u003e42 Secondary syphilis 395\u003c\/p\u003e \u003cp\u003e43 Ectodermal dysplasia 397\u003c\/p\u003e \u003cp\u003e44 Partial lipodystrophy 399\u003c\/p\u003e \u003cp\u003e45 Fabry’s disease 401\u003c\/p\u003e \u003cp\u003e46 Reiter’s syndrome\/reactive arthritis\/keratodermablennorrhagica 403\u003c\/p\u003e \u003cp\u003e47 Malignant melanoma 405\u003c\/p\u003e \u003cp\u003e48 Acanthosis nigricans 407\u003c\/p\u003e \u003cp\u003e49 Keratoacanthoma 410\u003c\/p\u003e \u003cp\u003e50 Pyoderma gangrenosum 411\u003c\/p\u003e \u003cp\u003e51 Psychogenic\/factitious 413\u003c\/p\u003e \u003cp\u003eStation 5 Locomotor 415\u003c\/p\u003e \u003cp\u003e1 Rheumatoid arthritis 416\u003c\/p\u003e \u003cp\u003e2 Psoriatic arthropathy 422\u003c\/p\u003e \u003cp\u003e3 Systemic sclerosis\/CREST syndrome 425\u003c\/p\u003e \u003cp\u003e4 Diabetic foot\/Charcot’s joint 428\u003c\/p\u003e \u003cp\u003e5 Tophaceous gout 431\u003c\/p\u003e \u003cp\u003e6 Ankylosing spondylitis 433\u003c\/p\u003e \u003cp\u003e7 Paget’s disease 435\u003c\/p\u003e \u003cp\u003e8 Osteoarthritis 437\u003c\/p\u003e \u003cp\u003e9 Marfan’s syndrome 439\u003c\/p\u003e \u003cp\u003e10 Vasculitis 441\u003c\/p\u003e \u003cp\u003e11 Proximal myopathy 442\u003c\/p\u003e \u003cp\u003e12 One leg shorter and smaller than the other 443\u003c\/p\u003e \u003cp\u003e13 Radial nerve palsy 444\u003c\/p\u003e \u003cp\u003e14 Arthropathy associated with infl ammatory bowel disease 445\u003c\/p\u003e \u003cp\u003e15 Polymyositis 447\u003c\/p\u003e \u003cp\u003e16 Systemic lupus erythematosus 448\u003c\/p\u003e \u003cp\u003e17 Old rickets 450\u003c\/p\u003e \u003cp\u003e18 Juvenile idiopathic arthritis 452\u003c\/p\u003e \u003cp\u003e19 Swollen knee 454\u003c\/p\u003e \u003cp\u003eStation 5 Endocrine 457\u003c\/p\u003e \u003cp\u003e1 Exophthalmos 458\u003c\/p\u003e \u003cp\u003e2 Acromegaly 461\u003c\/p\u003e \u003cp\u003e3 Graves’ disease 464\u003c\/p\u003e \u003cp\u003e4 Goitre 467\u003c\/p\u003e \u003cp\u003e5 Hypothyroidism 470\u003c\/p\u003e \u003cp\u003e6 Cushing’s syndrome 473\u003c\/p\u003e \u003cp\u003e7 Addison’s disease 478\u003c\/p\u003e \u003cp\u003e8 Hypopituitarism 481\u003c\/p\u003e \u003cp\u003e9 Pretibial myxoedema 483\u003c\/p\u003e \u003cp\u003e10 Gynaecomastia 485\u003c\/p\u003e \u003cp\u003e11 Turner’s syndrome 488\u003c\/p\u003e \u003cp\u003e12 Klinefelter’s syndrome\/hypogonadism 490\u003c\/p\u003e \u003cp\u003e13 Bitemporal hemianopia 494\u003c\/p\u003e \u003cp\u003e14 Diabetic foot\/Charcot’s joint 495\u003c\/p\u003e \u003cp\u003e15 Necrobiosis lipoidica diabeticorum 496\u003c\/p\u003e \u003cp\u003e16 Short stature 497\u003c\/p\u003e \u003cp\u003e17 Pseudohypoparathyroidism 499\u003c\/p\u003e \u003cp\u003e18 Pendred’s syndrome 502\u003c\/p\u003e \u003cp\u003eStation 5 Eyes 505\u003c\/p\u003e \u003cp\u003e1 Diabetic retinopathy 506\u003c\/p\u003e \u003cp\u003e2 Retinitis pigmentosa 511\u003c\/p\u003e \u003cp\u003e3 Optic atrophy 512\u003c\/p\u003e \u003cp\u003e4 Ocular palsy 514\u003c\/p\u003e \u003cp\u003e5 Visual field defect 515\u003c\/p\u003e \u003cp\u003e6 Retinal vein occlusion 516\u003c\/p\u003e \u003cp\u003e7 Old choroiditis 518\u003c\/p\u003e \u003cp\u003e8 Papilloedema 520\u003c\/p\u003e \u003cp\u003e9 Cataracts 522\u003c\/p\u003e \u003cp\u003e10 Myasthenia gravis 524\u003c\/p\u003e \u003cp\u003e11 Albinism 525\u003c\/p\u003e \u003cp\u003e12 Exophthalmos 526\u003c\/p\u003e \u003cp\u003e13 Myelinated nerve fibres 527\u003c\/p\u003e \u003cp\u003e14 Hypertensive retinopathy 528\u003c\/p\u003e \u003cp\u003e15 Glaucoma\/peripheral fi eld loss 530\u003c\/p\u003e \u003cp\u003e16 Retinal artery occlusion 532\u003c\/p\u003e \u003cp\u003e17 Asteroid hyalosis 533\u003c\/p\u003e \u003cp\u003e18 Drusen 534\u003c\/p\u003e \u003cp\u003e19 Laurence–Moon–Bardet–Biedl syndrome 535\u003c\/p\u003e \u003cp\u003e20 Cytomegalovirus choroidoretinitis (AIDS) 537\u003c\/p\u003e \u003cp\u003e21 Normal fundus 540\u003c\/p\u003e \u003cp\u003eStation 5 Other 541\u003c\/p\u003e \u003cp\u003e1 Bilateral parotid enlargement\/Mikulicz’s syndrome 542\u003c\/p\u003e \u003cp\u003e2 Deep venous thrombosis (DVT)\/Baker’s cyst\/cellulitis 543\u003c\/p\u003e \u003cp\u003e3 Peripheral vascular disease 546\u003c\/p\u003e \u003cp\u003e4 Osteogenesis imperfecta 548\u003c\/p\u003e \u003cp\u003e5 Down’s syndrome 549\u003c\/p\u003e \u003cp\u003e6 Pernicious anaemia 550\u003c\/p\u003e \u003cp\u003e7 Klippel–Feil syndrome 552\u003c\/p\u003e \u003cp\u003e8 Leg oedema 554\u003c\/p\u003e \u003cp\u003eAppendices 557\u003c\/p\u003e \u003cp\u003e1 Checklists 559\u003c\/p\u003e \u003cp\u003e2 Examination frequency of MRCP PACES short cases 563\u003c\/p\u003e \u003cp\u003e3 Texidor’s twinge and related matters 567\u003c\/p\u003e \u003cp\u003e4 Abbreviations 569\u003c\/p\u003e \u003cp\u003eIndex 572\u003c\/p\u003e","brand":"John Wiley and Sons Ltd","offers":[{"title":"Default Title","offer_id":49406855151959,"sku":"9781118348055","price":45.55,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9781118348055.jpg?v=1730497354","url":"https:\/\/bookcurl.com\/products\/an-aid-to-the-mrcp-paces-volume-3-9781118348055","provider":"Book Curl","version":"1.0","type":"link"}